Home › Therapeutic areas › Oncology › Myelofibrosis
Myelofibrosis (5 companies)
Companies with an active program in Myelofibrosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| IRON | Disc Medicine | GI/HepatologyHematology+2 Rare | 1 | Phase 3 | 9 |
| GERN | Geron | Oncology | 1 | Approved | 3 |
| KROS | Keros Therapeutics | NeurologyOncology Rare | 1 | Phase 3 | 4 |
| PRLD | Prelude Therapeutics | HematologyOncology Rare | 1 | Phase 1 | 3 |
| SNDX | Syndax Pharmaceuticals | ImmunologyOncology+1 Rare | 2 | Approved | 8 |
No companies match.